Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fujian Mintai Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company established in 1999 that specializes in the research, production, and sale of chemical drug substances and finished formulations. The company operates modern GMP-certified manufacturing facilities and produces a variety of essential medications, including cardiovascular treatments, anti-diabetic drugs, and broad-spectrum antibiotics. Mintai is known for its production of generic medicines such as enalapril maleate and metformin hydrochloride, serving both the hospital and retail pharmacy sectors in China. Beyond finished dosages, the company also engages in the production of active pharmaceutical ingredients (APIs) and bulk drug substances.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mintai Pharmaceutical.